Your session is about to expire
← Back to Search
Fluorocholine PET/CT Scan for Cancer Detection
Study Summary
This trial will study if a PET/CT scan can accurately detect benign/malignant tumors. Patients will receive a scan with a radioactive material & be monitored to see how accurate the scan is.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 4 trial • 60 Patients • NCT01749982Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I weigh less than 400 lbs and can fit into a 70 cm wide scanner.You have severe claustrophobia that cannot be controlled or managed.I am 18 years old or older.I can lie still for 30 minutes and handle an IV injection for a PET/CT scan.I am not currently experiencing any severe health crises like heart or breathing problems.My tumor is likely to show up on a specific PET scan.
- Group 1: Fluorocholine PET/CT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA given its stamp of approval to Fluorocholine PET/CT?
"The safety of Fluorocholine PET/CT was rated a 3 due to the abundance of data backing its efficacy and multiple trials vouching for its protection."
Are applicants aged 85 and under eligible for this research?
"This clinical investigation stipulates that patients must be between the age of 18 and 110 to qualify. Separate studies are available for those under 18 and over 65, totalling seven in number."
Who is eligible to partake in this medical research?
"For eligibility in this study, participants must meet the age requirement of being between 18 and 110 years old. Additionally, they should have had a fluorocholine pet/ct scan. The team is looking for approximately 2000 people to join the trial."
Are there still openings for potential participants in this research endeavor?
"At present, this clinical trial is not actively enrolling patients. Initially posted on November 30th 2022 and most recently updated on April 10th 2023, those looking to join a medical study may find success with the one trial seeking participants for fluorocholine PET/CT or any of the seven studies that use Fluorocholine PET/CT as an intervention."
Can you tell me the upper limit for participants in this clinical research?
"At this point in time, the trial is not taking on new participants. It was initially published to clinicaltrials.gov on November 30th 2022 and its most recent edit occurred April 10th 2023. If you are searching for alternatives, there are presently 1 study recruiting patients with fluorocholine PET/CT and 7 trials admitting individuals for Fluorocholine PET/CT therapy."
To what degree has Fluorocholine PET/CT been studied in prior research studies?
"Presently, there are 7 studies assessing the efficacy of Fluorocholine PET/CT. 2 of these active trials have progressed to Phase 3 testing. Montréal is home to multiple clinical trial sites, but other locations in Quebec also host investigations into this treatment modality."
Share this study with friends
Copy Link
Messenger